Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bluebird Bio (NQ: BLUE )

4.280 +0.140 (+3.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,997,706
Open 4.140
Bid (Size) 4.250 (13)
Ask (Size) 4.280 (3)
Prev. Close 4.140
Today's Range 4.070 - 4.330
52wk Range 2.865 - 32.68
Shares Outstanding 67,578,549
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering. 
Via Benzinga

Performance

YTD
-59.62%
-59.62%
1 Month
+44.11%
+44.11%
3 Month
-13.71%
-13.71%
6 Month
-57.16%
-57.16%
1 Year
-86.80%
-86.80%

More News

Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Bluebird (BLUE) Stock Soars 25% Following 2 FDA Recommendations
Via InvestorPlace
FDA Advisory Committee Backs Bluebird Bio's Blood Disorder Gene Therapy
Via Benzinga
Bluebird Bio Secures FDA Advisory Committee's Endorsement For Neurodegenerative Disease Drug
Via Benzinga
7 Oversold Stocks on the Verge of Blasting Off
Via InvestorPlace
89 Biggest Movers From Friday
Via Benzinga
The 5 Top Profit & Protection Stocks to Buy for 2022
Via InvestorPlace
Dow Jones Turns Lower; Revlon Shares Jump
Via Benzinga
33 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
U.S. Markets Open Higher; Dow Rises Around 200 Points
Via Benzinga
82 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
93 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Gold Down Over 2%; Electric Last Mile Solutions Shares Plummet
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Analysts Consider CRISPR Therapeutics' Blood Disorder Trial Data Encouraging, Impressive
Via Benzinga
Mid-Day Market Update: Nasdaq Dips Over 400 Points; Day One Biopharmaceuticals Shares Jump
Via Benzinga
70 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; Dow Drops 600 Points
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
FDA Advisory Committee Unanimously Supports beti-cel Gene Therapy for People with beta-thalassemia Who Require Regular Red Blood Cell Transfusions
From bluebird bio, Inc.
Via Business Wire
FDA Advisory Committee Unanimously Endorses eli-cel Gene Therapy for Cerebral Adrenoleukodystrophy
From bluebird bio, Inc.
Via Business Wire
bluebird bio stock trading halted today June 9th and tomorrow June 10th
From bluebird bio, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.